BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Follow Up Q&A Session To Lexicor Medical Technologies, Inc. Announcement About ADHD Assessment Aid


10/20/2005 3:04:47 PM

AUGUSTA, Ga., Oct. 19 /PRNewswire/ -- As a follow up to the announcement made on Oct. 6 about the NeuroLex Indicator Report Service, Lexicor Medical Technology will be hosting a short Q&A session on Oct. 20 at 11:15 a.m. EDT. To participate, please call 1-800-671-9342 and reference ID number 1697367.

What: Follow up question session to Lexicor Announcement on Oct. 6 When: Thursday, Oct. 20 @ 11:15 a.m. EDT Where: Call 1-800-671-9342 and reference ID number 1697367. More Info: View the video of the original announcement at: http://www.videonewswire.com/event.asp?id=30620 or read the news release at: http://www.lexicor.com/investor/lexicor_100605.asp. Contact: Mike Crisp at 1-864-298-1430 or crisp@hendersonadv.com.

The NeuroLex Indicator Report Service(SM) for ADHD, which uses QEEG, is the first scientifically-validated objective and non-invasive assessment aid based upon biological indicators rather than upon subjective pencil/paper tests. It is currently being used by medical providers -- primarily pediatricians -- across the country.

Several reporters have also asked for references to published peer- reviewed journal articles about the use of QEEG technology. Below are several articles for reference:

Chabot, R. J., di Michele, F., & Prichep, L. (2005). The role of quantitative electroencephalography in child and adolescent psychiatric disorders. Child and Psychiatric Clinics of North America, 14, 21-53. Monastra, VJ, Lubar, JF, and M Linden. The Development of a Quantitative Electroencephalographic: Scanning Process for Attention Deficit Hyperactivity Disorder: Reliability and Validity Studies. Neuropsychology. 15:1:136-144. 2001. Monastra, VJ, Lubar, JF, Linden M, VanDuesen, P, Green G, Wing W, Phillips, A, and TN Fenger. Assessing Attention Deficit Hyperactivity Disorder via Quantitative Electroencephalography: An Initial Validation Study. Neuropsychology. 13:3:424-433. 1999. Clarke, AR, Barry, RJ, McCarthy R, and M Selikowitz. EEG-defined Subtypes of Children with Attention Deficit Hyperactivity Disorder. Clinical Neurophysiology. 122:2098-2105. 2001. Clarke, AR, Barry, RJ, McCarthy R, and M Selikowitz. Excess Beta Activity in Children with Attention Deficit Hyperactivity Disorder: An Atypical Electrophysiological Group. Psychiatric Research. 103:2/3:205-218. 2001.

We hope you are able to participate in this conference call. If not, please call Mike Crisp at 864-298-1430 and he will help you set up an interview with a Lexicor spokesperson.

Video: http://www.videonewswire.com/event.asp?id=30620Lexicor Medical Technology

CONTACT: Mike Crisp at +1-864-298-1430, or crisp@hendersonadv.com, forLexicor Medical Technology



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES